Paul Offit

Q: What Schools Are Affiliated With Paul Offit

Paul Offit is affiliated with the following schools: Tufts University, Stanford University, University of Pennsylvania

Paul Offit's AcademicInfluence.com Rankings

Paul Offit

Biology

#458

World Rank

#817

Historical Rank

#273

USA Rank

Immunology

#179

World Rank

#187

Historical Rank

#56

USA Rank

biology Degrees

Download Badge

Biology

Why Is Paul Offit Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Paul Allan Offit is an American pediatrician specializing in infectious diseases, vaccines, immunology, and virology. He is the co-inventor of a rotavirus vaccine. Offit is the Maurice R. Hilleman Professor of Vaccinology, professor of pediatrics at the Perelman School of Medicine at the University of Pennsylvania, former chief of the Division of Infectious Diseases , and the director of the Vaccine Education Center at the Children's Hospital of Philadelphia.

(See a Problem?)

Paul Offit's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. (2006) (1615)
Vaccines and autism: a tale of shifting hypotheses. (2009) (297)
Addressing parents' concerns: do multiple vaccines overwhelm or weaken the infant's immune system? (2002) (292)
Identification of the two rotavirus genes determining neutralization specificities (1986) (259)
Rotavirus isolate WI61 representing a presumptive new human serotype (1987) (241)
Molecular basis of rotavirus virulence: role of gene segment 4 (1986) (207)
Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7 (1986) (202)
Antigenic mapping of the surface proteins of rhesus rotavirus. (1986) (191)
The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants. (1996) (189)
Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies (1985) (185)
Reassortant rotaviruses containing structural proteins vp3 and vp7 from different parents induce antibodies protective against each parental serotype (1986) (171)
SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants. (2021) (168)
Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants. (2004) (156)
Addressing parents' concerns: do vaccines contain harmful preservatives, adjuvants, additives, or residuals? (2003) (146)
Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices (2001) (131)
Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants. (2006) (122)
Rotavirus-specific cytotoxic T lymphocytes appear at the intestinal mucosal surface after rotavirus infection (1989) (121)
The Cutter incident, 50 years later. (2005) (113)
Plotkin's Vaccines (2017) (112)
Vaccine Safety: Myths and Misinformation (2020) (110)
Communicating science to the public: MMR vaccine and autism. (2003) (108)
Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002. (2002) (106)
Identification of the simian rotavirus SA11 genome segment 3 product. (1988) (102)
A murine model for oral infection with a primate rotavirus (simian SA11) (1984) (102)
Vaccine safety (1998) (101)
Development of a pentavalent rotavirus vaccine against prevalent serotypes of rotavirus gastroenteritis. (2005) (101)
Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to the heterotypic neutralization domain of VP7 and the VP8 fragment of VP4 (1989) (100)
Immune response of infants and children to low-passage bovine rotavirus (strain WC3). (1986) (100)
The Problem With Dr Bob's Alternative Vaccine Schedule (2009) (93)
Addressing parents' concerns: do vaccines cause allergic or autoimmune diseases? (2003) (93)
Host factors associated with protection against rotavirus disease: the skies are clearing. (1996) (93)
Perspectives on the receipt of a COVID-19 vaccine: A survey of employees in two large hospitals in Philadelphia (2021) (90)
Rotavirus-specific cytotoxic T lymphocytes passively protect against gastroenteritis in suckling mice (1990) (87)
Why are pharmaceutical companies gradually abandoning vaccines? (2005) (87)
A randomized trial to increase acceptance of childhood vaccines by vaccine-hesitant parents: a pilot study. (2013) (84)
Rotavirus pathology and pathophysiology. (1994) (82)
Memory and distribution of virus-specific cytotoxic T lymphocytes (CTLs) and CTL precursors after rotavirus infection (1991) (73)
Maternal antibody-mediated protection against gastroenteritis due to rotavirus in newborn mice is dependent on both serotype and titer of antibody. (1985) (72)
Developing a SARS-CoV-2 Vaccine at Warp Speed. (2020) (71)
Rotavirus-specific cytotoxic T lymphocytes cross-react with target cells infected with different rotavirus serotypes (1988) (66)
Enhancement of rotavirus immunogenicity by microencapsulation. (1994) (65)
Response of mice to rotaviruses of bovine or primate origin assessed by radioimmunoassay, radioimmunoprecipitation, and plaque reduction neutralization (1983) (65)
Thimerosal and vaccines--a cautionary tale. (2007) (65)
Racial/Ethnic Differences in COVID-19 Vaccine Hesitancy Among Health Care Workers in 2 Large Academic Hospitals (2021) (64)
Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation (2003) (64)
Employee designation and health care worker support of an influenza vaccine mandate at a large pediatric tertiary care hospital. (2011) (62)
Vaccines and autism revisited--the Hannah Poling case. (2008) (62)
The New Pentavalent Rotavirus Vaccine Composed of Bovine (Strain WC3) -Human Rotavirus Reassortants (2006) (62)
Primary Murine Small Intestinal Epithelial Cells, Maintained in Long-Term Culture, Are Susceptible to Rotavirus Infection (2000) (59)
VP4 genotyping of human rotavirus in the United States (1994) (58)
Principal Controversies in Vaccine Safety in the United States. (2019) (58)
Rotavirus-specific humoral and cellular immune response after primary, symptomatic infection. (1993) (58)
Autism's False Prophets: Bad Science, Risky Medicine, and the Search for a Cure (2008) (55)
Deadly Choices: How the Anti-Vaccine Movement Threatens Us All (2010) (55)
Migration of antigen-presenting B cells from peripheral to mucosal lymphoid tissues may induce intestinal antigen-specific IgA following parenteral immunization. (1999) (52)
The cultivation of human rotavirus, strain 'Wa', to high titer in cell culture and characterization of the viral structural polypeptides. (1983) (51)
Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infants. (1995) (51)
Rotaviruses: Immunological Determinants of Protection Against Infection and Disease (1994) (49)
Rotavirus-specific proteins are detected in murine macrophages in both intestinal and extraintestinal lymphoid tissues. (1998) (48)
Rotavirus immunoglobulin a responses stimulated by each of 3 doses of a quadrivalent human/bovine reassortant rotavirus vaccine. (2004) (47)
Induction of virus-specific antibody production by lamina propria lymphocytes following intramuscular inoculation with rotavirus. (1995) (45)
Outer capsid glycoprotein vp7 is recognized by cross-reactive, rotavirus-specific, cytotoxic T lymphocytes. (1991) (45)
Circulating rotavirus-specific antibody-secreting cells (ASCs) predict the presence of rotavirus-specific ASCs in the human small intestinal lamina propria. (2000) (44)
WC3 reassortant vaccines in children. (1996) (43)
Vaccines for rotavirus gastroenteritis universally needed for infants. (2004) (43)
Immunologic correlates of protection against rotavirus challenge after intramuscular immunization of mice (1997) (42)
Rotavirus-specific helper T cell responses in newborns, infants, children, and adults. (1992) (39)
Rotavirus serotype-specific neutralizing activity in human milk. (1988) (39)
B2 but Not B1 Cells Can Contribute to CD4+ T-Cell-Mediated Clearance of Rotavirus in SCID Mice (2001) (38)
Oral inoculation of mice with low doses of microencapsulated, noninfectious rotavirus induces virus-specific antibodies in gut-associated lymphoid tissue. (1995) (38)
Hypertrophy, hyperplasia, and infectious virus in gut-associated lymphoid tissue of mice after oral inoculation with simian-human or bovine-human reassortant rotaviruses. (2001) (37)
Influence of potential protective mechanisms on the development of live rotavirus vaccines. (2010) (35)
The meningococcal vaccine--public policy and individual choices. (2003) (35)
The impact of access to immunization information on vaccine acceptance in three countries (2017) (33)
Noninfectious rotavirus (strain RRV) induces an immune response in mice which protects against rotavirus challenge (1989) (32)
Gastroenteritis Caused By Human Rotaviruses (Serotype Three) In A Suckling Mouse Model* (1987) (31)
Relative Importance of Rotavirus-Specific Effector and Memory B Cells in Protection against Challenge (1998) (31)
Rotavirus-specific intestinal immune response in mice assessed by enzyme-linked immunospot assay and intestinal fragment culture. (1994) (29)
COVID-19 vaccines for children. (2021) (28)
Studying complementary and alternative therapies. (2012) (27)
Addressing the Challenges of Serogroup B Meningococcal Disease Outbreaks on Campuses (2014) (26)
The future of rotavirus vaccines. (2002) (26)
Induction of rotavirus-specific cytotoxic T lymphocytes by vaccinia virus recombinants expressing individual rotavirus genes. (1994) (23)
Ampicillin-Resistant, β-Lactamase-Negative Haemophilus influenzae Type b (1982) (22)
Vaccinated: One Man's Quest to Defeat the World's Deadliest Diseases (2007) (22)
RotaTeq: a pentavalent bovine--human reassortant rotavirus vaccine. (2006) (22)
Bad Faith: When Religious Belief Undermines Modern Medicine (2015) (22)
Response of adult human volunteers to oral administration of bovine and bovine/human reassortant rotaviruses. (1986) (22)
The development of COVID-19 vaccines in the United States: Why and how so fast? (2021) (21)
Severe Epstein-Barr virus pulmonary involvement. (1981) (21)
Do You Believe in Magic? The Sense and Nonsense of Alternative Medicine (2013) (21)
Enhancement by microencapsulation of rotavirus-specific intestinal immune responses in mice assessed by enzyme-linked immunospot assay and intestinal fragment culture. (1995) (20)
Presence of three P types (VP4 serotypes) and two G types (VP7 serotypes) among bovine rotavirus strains (2005) (20)
Correlates of protection against rotavirus infection and disease. (2008) (20)
Infant immune response to human rotavirus serotype G1 vaccine candidate reassortant WI79-9: different dose response patterns to virus surface proteins VP7 and VP4 (2004) (20)
Induction of Mucosal B-Cell Memory by Intramuscular Inoculation of Mice with Rotavirus (1998) (19)
Upper airway obstruction in association with perinatally acquired herpes simplex virus infection. (1992) (19)
Polypeptide specificity of antiviral serum antibodies in children naturally infected with human rotavirus (1990) (19)
Bad Advice: Or Why Celebrities, Politicians, and Activists Aren't Your Best Source of Health Information (2018) (18)
Evaluation of a bovine-human rotavirus reassortant vaccine in infants. (1993) (18)
Neutralizing antibodies to heterologous animal rotavirus serotypes 5, 6, 7, and 10 in sera from Ecuadorian children (1991) (18)
Immunologic determinants of protection against rotavirus disease. (1994) (18)
Effect of Water-Based Microencapsulation on Protection against EDIM Rotavirus Challenge in Mice (1998) (17)
Aqueous-based microencapsulation enhances virus-specific humoral immune responses in mice after parenteral inoculation. (1996) (17)
The science of vaccine safety: Summary of meeting at Wellcome Trust. (2020) (15)
Distribution of rotavirus-specific memory B cells in gut-associated lymphoid tissue after primary immunization. (2001) (15)
Coronavirus disease 2019 (COVID-19) vaccine hesitancy among physicians, physician assistants, nurse practitioners, and nurses in two academic hospitals in Philadelphia (2021) (14)
On the Shoulders of Giants - From Jenner's Cowpox to mRNA Covid Vaccines. (2021) (13)
Effect of microencapsulation on immunogenicity of a bovine herpes virus glycoprotein and inactivated influenza virus in mice. (1997) (13)
Rotavirus-specific cytotoxic T lymphocyte response of mice after oral inoculation with candidate rotavirus vaccine strains RRV or WC3. (1989) (13)
Bad Advice (2018) (12)
Unusual presentation of group B Streptococcus osteomyelitis. (1992) (11)
Covid-19 Boosters — Where from Here? (2022) (11)
Adjuvants, Additives, or Residuals? Addressing Parents' Concerns: Do Vaccines Contain Harmful Preservatives, (2005) (11)
Bivalent Covid-19 Vaccines - A Cautionary Tale. (2023) (11)
Vaccines Against Human Hookworm Disease (2004) (10)
Treatment With Quadrivalent Human Papillomavirus Vaccine for Juvenile-Onset Recurrent Respiratory Papillomatosis: Case Report and Review of the Literature (2017) (10)
Challenges to Developing a Rotavirus Vaccine. (2017) (10)
Vaccines and Your Child: Separating Fact from Fiction (2011) (10)
25 – Development of a Mucosal Rotavirus Vaccine (1996) (10)
Tactile Defensiveness and Discrimination Test-Revised (2021) (9)
Preventing harm from thimerosal in vaccines. (2000) (9)
Should childhood vaccination be mandatory? Yes (2012) (9)
The power of ‘box a’ (2003) (9)
New vaccines against mucosal pathogens: rotavirus and respiratory syncytial virus. (1997) (8)
II, 13. Current state of development of human rotavirus vaccines (2003) (8)
Ampicillin-resistant, beta-lactamase-negative haemophilus influenzae type b. (1982) (8)
Acyclovir therapy in neonatal herpes simplex virus infection. (1982) (8)
Comprar Vaccines, 5th Edition: Expert Consult | Paul A. Offit | 9781416036111 | Saunders (2008) (7)
Rotavirus-specific antibodies in fetal bovine serum and commercial preparations of serum albumin (1984) (7)
Incomplete financial disclosure in a viewpoint on complementary and alternative therapies. (2012) (7)
Meningococcal conjugate vaccine in the UK: an update (2004) (7)
Delaying vaccination is not a safer choice. (2013) (7)
Japanese physicians’ attitudes and intentions regarding human papillomavirus vaccine compared with other adolescent vaccines (2019) (6)
A quantitative luminescence assay for measuring cell uptake of aqueous-based microcapsules in vitro. (2000) (6)
Rotavirus-specific protein synthesis is not necessary for recognition of infected cells by virus-specific cytotoxic T lymphocytes (1989) (6)
Preventing harm from thimerosal in vaccines [3] (multiple letter) (2000) (6)
30 – Rotavirus vaccines (2013) (6)
Vaccines and Autism (2002) (5)
Relative Importance of Rotavirus-Specific Effector and Memory B Cells in Protection against Challenge (1998) (4)
How vaccine safety is monitored before and after licensure. (2001) (4)
Communicating vaccine science to the public. (2014) (4)
Vaccines and autism in primate model (2015) (4)
The Vaccine Schedule (2011) (3)
New Book About Vaccine Safety (2008) (3)
Vaccine Safety (2017) (3)
Comparison of immunization systems in Japan and the United States - What can be learned? (2020) (3)
52 – Rotavirus Vaccines (2018) (3)
Thimerosal and autism (2004) (3)
The Anti-Vax Movement and What Allergists Can Do. (2020) (3)
Improving vaccine policy making: A dose of reality. (2020) (3)
1076 ROTAVIRUSES (RV) OF BOVINE AND HUMAN ORIGIN: IMMUNE RESPONSE OF ADUIITS AND CHILDREN FOLLOWING ORAL ADMINISTRATION (1985) (3)
Implementation of a Mandatory Influenza Vaccine Policy: A 10-Year Experience. (2020) (3)
Specific attachment of aqueous-based microcapsules to macrophages, B cells, and dendritic cells in vitro (2002) (3)
Viral diseases: infections of the gastrointestinal tract. (1982) (3)
Rotavirus Vaccines: Round Two (2006) (2)
Could fever improve COVID-19 outcomes? (2020) (2)
Vaccine mandates in France will save lives (2018) (2)
A statement regarding personal belief exemption from immunization mandates: from the Pediatric Infectious Diseases Society, March 2011. (2011) (2)
Determination of efficiency of attachment of biotinylated antibodies to avidin-linked, aqueous-based microcapsules by flow cytometry. (2003) (2)
Rotavirus vaccine (1998) (2)
Rotavirus vaccine (1999) (1)
Viral Microencapsulation Delays Protection after Intramuscular Inoculation of Mice with Rotavirus (1999) (1)
Too many vaccinations ? Authors' reply (2002) (1)
Diseases? Addressing Parents' Concerns: Do Vaccines Cause Allergic or Autoimmune (2005) (1)
Preface to the Seventh Edition (2018) (1)
Polio revisited Gareth Williams Paralysed with Fear: the (2013) (1)
Do You Believe in Magic (2013) (1)
Why Aren't International Travelers Vaccinated for Measles? (2017) (1)
Motion picture sickness (2016) (1)
Important New Resource for Clinicians Giving Expert Witness Testimony on Vaccines. (2018) (1)
Don’t Hesitate – Vaccinate! (2020) (1)
Rotavirus Vaccines Part II: Raising the Bar for Vaccine Safety Studies (2011) (1)
Vaccinations and Autism (2021) (1)
Immunologic methods and correlates of protection. (2000) (1)
The “ Wakefield ” Studies : Studies Hypothesizing That MMR Causes Autism (2005) (0)
Don't Force Parents to Vaccinate Their Kids. Incentivize Them to Do It (2020) (0)
9. Science and the Media (2008) (0)
Complementary Health Practices—Reply (2012) (0)
In vitro production of rotavirus specific immuno globulin a after oral immunization of humans (1984) (0)
Vaccines handbook : mobile version : a companion to Plotkin, Orenstein's and Offit's Vaccines (2009) (0)
5. Mercury Rising (2008) (0)
Vaccine Exemptions: When Do Individual Rights Trump Societal Good? (2015) (0)
The Vaccine-Autism Controversy (2017) (0)
7. Behind the Mercury Curtain (2008) (0)
Contributors (2008) (0)
Following Parenteral Immunization May Induce Intestinal Antigen-Specific IgA Peripheral to Mucosal Lymphoid Tissues Migration of Antigen-Presenting B Cells from (1999) (0)
Ethical considerations in the vaccine life cycle : an overview (2013) (0)
Vaccines for Adolescents and Teens (2011) (0)
11. A Place for Autism (2008) (0)
Vaccines Against Rotavirus Gastroenteritis (2016) (0)
Recombinant vaccine rotavirus. (1991) (0)
Flawed research and its enduring repercussions (2020) (0)
The Cutter Incident (2017) (0)
In Memoriam (2012) (0)
Don’t Hesitate – Vaccinate! (2008) (0)
Vaccine safety (2008) (0)
1. The Tinderbox (2008) (0)
6. Mercury Falling (2008) (0)
Chapter 1. Little White Coffins (2017) (0)
a VaccineEducationCenter,Children'sHospitalofPhiladelphia,Philadelphia,Pennsylvania; b DepartmentofPediatrics,SchoolofMedicine,UniversityofPennsylvania, (2009) (0)
Maintaining the public's trust in immunizations. (2000) (0)
Communicating with Health Care Professionals (2009) (0)
Calming a Parent's Vaccine Fears (2016) (0)
Vaccines: An Educational Imperative & Opportunity for Biology Teachers (2019) (0)
Status of rubella vaccines (1981) (0)
Liaisons from Organizations (2010) (0)
Back to the future (2004) (0)
Preface to the sixth edition (2013) (0)
3. The Implosion (2008) (0)
5 Things We Know to Be True. (2016) (0)
Vaccination Has Eliminated Infectious Diseases at the Price of Causing Chronic Diseases (2008) (0)
4. A Precautionary Tale (2008) (0)
Book Review: Rejoinder from the author (2014) (0)
Pertussis and Autism (2021) (0)
Measles Virus RNA and Autism Revisited (2004) (0)
Chapter 9. Death for the Lambs (2017) (0)
10. Science and Society (2008) (0)
COVID-19 Vaccines in Young Children-Reassuring Evidence for Parents. (2023) (0)
Intestinal virus-specific IgA production following IM immunization is induced by non-immune, antigen-presenting B cells. (1999) (0)
Vaccines in the First Year of Life (2011) (0)
Understanding the Anti-Vaccine Movement (2009) (0)
Subunitary vaccine encapsulation against virus of bovine herpes type 1 based on a water solvent. (1998) (0)
110 Hard Knocks: Communicating Science to the Public (2012) (0)
Vaccines, Calling the Shots (2014) (0)
Compassionate Use for Public Health (2014) (0)
Combating 'Vaccine Hesitancy,' Northwest Health Initiative Reports Gains (2020) (0)
Killing Us Softly (2013) (0)
Rotavirus Infection of Cultured Primary Murine Small Intestinal Epithelial Cells 874 (1998) (0)
Measles and Autism (2021) (0)
Epilogue: “Next, on Oprah” (2008) (0)
8. Science in Court (2008) (0)
Perception of Japanese Physicians about Human Papillomavirus Vaccine (2017) (0)
Vaccines in the Second Year of Life (2011) (0)
2. Lighting the Fuse (2008) (0)
Preface to the fifth edition (2008) (0)
CIRCULATING ROTAVIRUS-SPECIFIC ANTIBODY-SECRETING CELLS (ASCs) ARE A PREDICTOR OF ASCs IN THE HUMAN SMALL INTESTINE LAMINA PROPRIA (1999) (0)
Celebrating the Centennial of the Birth of the World's Greatest Vaccinologist, Maurice R. Hilleman, 1919-2005. (2020) (0)
against Challenge Effector and Memory B Cells in Protection Relative Importance of Rotavirus-Specific (2013) (0)
Bivalent Covid-19 Vaccines. Reply. (2023) (0)
Measles-Mumps-Rubella (MMR) Vaccination (2021) (0)
"Stay the Course: Science, Prevention, Education, Training, Evaluation & Update!" (2016) (0)
659A comparison of local determinants of vaccine hesitancy in Botswana and the Dominican Republic, two middle-income countries (2014) (0)
Immunization Symposium (2020) (0)
Thiothixene Hydrochloride (2020) (0)

This paper list is powered by the following services:

Other Resources About Paul Offit

What Schools Are Affiliated With Paul Offit?

Paul Offit is affiliated with the following schools:

Paul Offit's Academic­Influence.com Rankings